On Tuesday, November 22, the Ministry of Health, Labour and Welfare (MHLW) of Japan approved Shionogi’s Xocova® Tablets 125 mg (Generic name: ensitrelvir fumaric acid, Code No.: S-217622) for the treatment of COVID-19. This is the first manufacturing and marketing approval under the emergency regulatory approval system and the first domestically produced oral agent against … Continue reading New COVID-19 drug developed by Shionogi & Co., Ltd. and Hokkaido University approved in Japan